May 23, 2025

Peer Fischer elected Fellow of AIMBE

Peer Fischer elected Fellow of AIMBE

Peer Fischer, research group leader at the Max Planck Institute for Medical Research in Heidelberg and Professor at the Institute for Molecular Systems Engineering and Advanced Materials at Heidelberg University, has been elected a Fellow of the American Institute for Medical and Biological Engineering (AIMBE).

  • Election to the AIMBE College of Fellows is one of the highest professional honors for medical and biotechnology engineers.
  • Peer Fischer was honored “for pioneering contributions in nanorobotics, the development of new ultrasound technologies, and for his leadership and engagement in translational science.”
Peer Fischer with the President of AIMBE Lola Eniola-Adefeso (right) and Yongjie Jessica Zhang, Chair of the Fellows 2024 (left).
© AIMBE

“The appointment is a great honor,” says Peer Fischer. ”I would like to thank my colleagues for their recognition and am particularly pleased that the interface between science and technology transfer, a balancing act between the disciplines in our research, has been honored in this way. This also shows that we are on the right track with our institute’s First in Translation plans for our new location in Heilbronn.”

The First in Translation initiative of the Max Planck Institute for Medical Research (MPIMR) prepares fundamental research discoveries for entrepreneurial application. With support from the Dieter Schwarz Foundation, the MPIMR is currently setting up a second site on Heilbronn’s Bildungscampus, which will also provide a home for the institute’s First in Translation activities.

Honor for pioneering work

Membership, according to AIMBE, honors individuals who have made “outstanding contributions to engineering and medicine research, practice, or education” as well as to “the pioneering of new and developing fields of technology, making major advancements in traditional fields of medical and biological engineering or developing/implementing innovative approaches to bioengineering education.”

AIMBE College of Fellows Class of 2025

The induction ceremony into the “2025 Class of the AIMBEE College of Fellows” took place during the AIMBE annual event in Arlington, Virginia, USA, on March 31, 2025. Peer Fischer was inducted along with around 170 colleagues from more than 30 countries who make up the AIMBE College of Fellows Class of 2025.

Our latest News

discover more
GalaTek GmbH and a:head bio AG Announce Strategic Collaboration to Automate Human Brain Organoid Workflows

GalaTek GmbH and a:head bio AG Announce Strategic Collaboration to Automate Human Brain Organoid Workflows

Vienna, Austria – October 22, 2025 – GalaTek GmbH, a leading innovator in laboratory automation technologies, and a:head bio AG, a pioneering biotech company specializing in human brain organoid research, today announced a strategic collaboration aimed at advancing the automation of brain organoid workflows. The partnership aims to integrate GalaTek’s advanced robotics and software platforms with […]

Clean Tech Innovation Day & Solar TAP Industry Day: Advanced solutions are needed

Clean Tech Innovation Day & Solar TAP Industry Day: Advanced solutions are needed

Heidelberg, Germany, October 22, 2025 – It’s all about a sustainable, smarter energy future: Clean Tech Innovation Day & Solar TAP Industry Day showed that this can only be achieved with a shared mission and vision. More than 70 participants from science, industry, and start-ups took the opportunity at the Heidelberg Congress Center to exchange […]

Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia

Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia

Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia Paris, October 17, 2025. The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Wayrilz (rilzabrutinib) as a new treatment for immune thrombocytopenia (ITP) in adult patients who are refractory to other […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp